The prevalence of stroke increases with age and the ability to absorb all nutrients from our diets decreases with age. Nutrition is a modifiable risk factor for stroke, which is a leading cause of death and disability in worldwide. Deficiencies in one-carbon metabolism, including in methyltetrahydrofolate reductase (MTHFR), have been linked to increased risk of stroke. The Mthfr +/− mice mouse model mimic the phenotype of the MTHFR677C➔T polymorphism, such as elevated levels of homocystine. Using this mouse model, the aim of this study was to investigate the impact of dietary supplementation with 5-methylTHF, vitamin B12, and choline after ischemic stroke. Male Mthfr +/− and wildtype littermate control mice were aged (~1.5-year-old) and were placed on control diet (CD) 4-weeks prior to sensorimotor cortex damage using photothrombosis (PT), a model for ischemic stroke. Post-operatively, one group of Mthfr +/− and wildtype littermate mice were placed on 5-methylTHF, vitamin B12, and choline supplemented diet (SD). Four weeks after PT and SD motor function was assessed using the accelerating rotarod, forepaw asymmetry, and ladder beam walking tasks. Total homocysteine and cysteine levels were measured in blood. Brain tissue was processed to assess lesion volume and investigate biochemical and molecular changes. After PT and SD, Mthfr +/− mice were able to stay on the accelerating rotarod longer and used their impaired forepaw to explore more when compared to CD animals. Furthermore, total homocysteine levels in plasma and lesion volume were reduced in Mthfr +/+ and Mthfr +/− SD mice. Within the damage site, there were reduced levels of apoptotic cell death and increased neuroprotective cellular response in the brains of SD treated Mthfr +/− mice. This study reveals a critical role for one-carbon supplementation, with 5-methylTHF, vitamin B12, and choline, in supporting improvement after ischemic stroke damage.
Introduction
Ischemic stroke is considered a major health and economic problem worldwide and, more importantly, it is a growing burden in the increasingly aging population (Feigin et al., 2015; Mozaffarian et al., 2015) . Age is a non-modifiable risk factor for all subtypes of stroke, particularly ischemic stroke (Feigin et al., 2015; WHO MONICA Project Principal Investigators, 1988) . In older adults the occurrence of stroke is greater and the impairments are more severe (Kelly-Hayes et al., 2003; Long et al., 2016; Vijayan and Reddy, 2016) . Older adults are also at a higher risk for nutritional deficiencies because of changes in metabolism and absorption (Kehoe et al., 2019; Moore et al., 2018) . Diet is a common modifiable risk factor for stroke (Kumar et al., 2016; Mozaffarian et al., 2015) . B-vitamins, such as folic acid, are well known for their role in neurodevelopment (Ali and Economides, 2000) , but have also been implicated in the onset and progression of stroke (Hankey, 2018; Spence, 2013; Spence et al., 2017) .
One-carbon metabolism consists of several B-vitamins and the enzyme, methylenetetrahydrofolate reductase (MTHFR), that catalyzes the irreversible conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate (5-methylTHF). The methyl groups from 5-methylTHF is a substrate in the vitamin-B12-dependent methylation of homocysteine to form methionine by methionine synthase. Reduced function of MTHFR results in increased levels of homocysteine. A polymorphism in MTHFR (677C➔T) results in reduced enzymatic activity, increased levels of homocysteine, and risk of vascular diseases (Frosst et al., 1995) such as stroke (Abhinand et al., 2017; Casas et al., 2005; Li et al., 2017; Sobczyńska-Malefora et al., 2016; Song et al., 2016) . The China Stroke Primary Prevention Trial reported that Enalapril in combination with folic acid reduced levels of homocysteine and the number of ischemic stroke events in hypertensive patients with the MTHFR 677TT polymorphism (Zhao et al., 2017a (Zhao et al., , 2017b . This study highlights the importance of tailored interventions. Whereas, other studies in patients without the polymorphism have reported that there is no positive impact of B-vitamin supplementation on stroke (Bonaa, 2006; House et al., 2010; Toole et al., 2004) . The impact of dietary B-vitamin supplementation on risk of ischemic stroke requires further investigation (Hankey and JW, 2008; Spence et al., 2017) .
In our work using wild-type mice with increased levels of dietary folic acid, vitamin B12, riboflavin, and choline, we have reported improved functional outcome and increased neuroplasticity after ischemic damage induced by photothrombosis . Additionally, in non-disease models, the beneficial effects of dietary 5-methylTHF supplementation have also been described (Hyndman et al., 2015; Spiegelstein et al., 2004) . The impact of 5-methylTHF supplementation after ischemic stroke during MTHFR-deficiency is not well understood. Using the heterozygote Mthfr +/− mice, which model aspects of the MTHFR polymorphism, we have previously demonstrated that ischemic damage leads to reduced neuronal and astrocyte viability using in vitro models of stroke . Furthermore, aged MTHFR mice are more impaired functionally after damage to the sensorimotor cortex . The aim of this study was to evaluate the impact of supplementation with 5-methylTHF combined with vitamin B12 and choline on functional outcome and damage after ischemic stroke in aged male MTHFR-deficient mice.
Materials & methods

Animals and experimental design
All experiments performed in this study were in accordance with the Canadian Council on Animal Care (CCAC). Male 18-month-old Mthfr +/ + (n = 18) and Mthfr +/− (n = 18) littermate C57BL/6 mice were used in the study. From birth until 18-months of age animals were maintained on a diet of standard mouse chow and water ad-libitum. The standard mouse chow used was from Teklad Global 14% protein from Envigo (2014), it contained 0.03 mg/kg of vitamin B12, 1030 mg/kg of choline bitrate, and 0 mg/kg of 5-methylTHF according to the Recommended Dietary Allowance (RDA) for rodents set by the American Institute of Nutrition (Reeves, 1997) . Experimental manipulations are outlined in Fig. 1 . Four weeks prior to ischemic damage using photothrombosis (PT) mice were put on a control diet (CD) (Envigo). Immediately after PT one group of Mthfr +/+ and Mthfr +/− mice were maintained on a CD, while another group were placed on a supplemented diet (SD) (Envigo). The CD (TD.01369) contained 0.025 mg/kg of vitamin B12, 1150 mg/kg of choline bitrate according to the Recommended Dietary Allowance (RDA) for rodents set by the American Institute of Nutrition (Reeves, 1997) . Whereas the SD (TD.180437) contained 0.5 mg/kg of vitamin B12, 4950 mg/kg of choline bitrate, and 4 mg/kg of 5-methylTHF. In our previous work we have used the same levels of folic acid, vitamin B12 and choline bitrate . The levels of 5-methylTHF used for this study were previously reported to have beneficial effects in vivo (Spiegelstein et al., 2004) . Both CD and SD contained 2 mg/kg of folic acid and 3.3 g/ kg L-methionine and to inhibit folate production by intestinal flora, 1% succinylsulfathiazole. Mice were housed in a controlled environment (12 h/12 h light/dark cycle, 18-24°C) with ad libitum access to food and water. All animals were randomly assigned to experimental groups. For the duration of study, animals were weighed weekly.
Photothrombosis
At 18-months of age, all male mice were anaesthetized with isoflurane (1.5%) in a 70:30 nitrous oxide: oxygen mixture. Core body temperature was maintained at 37.0 ± 0.2°C using an automated heat blanket with temperature feedback (Harvard Apparatus). Focal ischemic damage was targeted to the sensorimotor cortex (mediolateral +0.24 mm) Lee et al., 2004 ). An intraperitoneal injection of 10 mg/kg photoactive Rose Bengal (Sigma) was given 5 min prior to a 532 nm green laser (Beta Electronics) exposure, the laser was placed 2 cm above the skull for 15 min.
Behavioral testing
Bederson exam
Motor function was measured 4 weeks after PT damage. We used the Bederson exam to evaluate symmetry, forepaw outstretching, climbing, and reflex (perfect score = 0) (Bederson et al., 1986) . The investigator that performed all neurological testing on mice were blinded to the treatment groups.
Forepaw asymmetry
Forepaw asymmetry was measured by using a cylinder (19 cm high, 14 cm in diameter) made of thick glass. The mouse was placed in the glass cylinder for 10 min and video was recorded from the side. Forepaw contacts with the wall of the cylinder were counted. The first 10 movements were scored during the 10-min test. The final score was calculated as follows: final score = (number of non-impaired forelimb movementnumber of impaired forelimb movement)/ (sum of all movements). A positive score thus indicated favored use of the nonimpaired forelimb, a negative indicated favored use of the impaired forelimb and a score of zero indicated equal use of both non-impaired and impaired forelimbs upon rearing and exploration of the cylinder walls Theoret et al., 2015) .
Rotarod
Animals were tested on a standard rotarod (IITC Life Sciences) (Jones and Roberts, 1968) . The metal rotarod cylinder was 0.75 in. in diameter and 18 in. long. The cylinder was positioned 12 in. from the ground by a Plexiglas container and moved by a rubber belt connected to a small motor. Animals were tested on an accelerating rotarod (4 to 60 rpm) over 8 min. The latency to fall, distance travelled, and top speed were recorded. Animals were tested on a single day with three separate trials with an inter trial interval of 5 min McIntosh and Jadavji, 2017; Zhang et al., 2018) .
Ladder beam
The ladder rung apparatus was composed of two Plexiglas walls. Each wall contained holes located at the bottom edge of the wall; the holes could be filled with metal bars. The entire apparatus was placed atop two standard mouse housing cages. The performance was videorecorded from the side, with the camera positioned at a slight ventral angle so that all 4 limbs could be recorded at the same time (Farr et al., 2006) .
All video recordings were analyzed frame-by-frame. Each step was scored according to the quality of limb placement as previously described (Farr et al., 2006) . For analysis of foot placement accuracy, the number of errors in each session was counted. The error score was calculated from the total number of errors and the number of steps for each limb (Farr et al., 2006) .
Brain tissue
After the completion of behavioral testing, animals were euthanized using the perfusion method. Brain tissue and blood were collected for molecular analysis. Brain tissue was fixed in 4% paraformaldehyde (PFA) for 24 h. Using a cryostat, brain tissue was sectioned at 30 μm thickness then mounted on slides in serial order.
Lesion volume was quantified using slide mounted brain tissue stained with cresyl violet (Sigma) and ImageJ (NIH) software , every sixth section was quantified. Briefly, lesion area was traced, and the sum of the lesion area was multiplied by the section thickness and number of sections. Each animal had a minimum of six sections that were used for quantification.
Plasma homocysteine levels
Cardiac blood was obtained at euthanization from mice, collected in potassium-EDTA tubes centrifuged for 7 min at 7000 xg at 4°C to obtain plasma, which was frozen at −80°C until analysis.
Total plasma homocysteine (tHcy) and cysteine (tCys) levels were measured by liquid chromatography tandem mass spectrometry (LC-MS/MS) as previously described (Ducros et al., 2006) , with modification to include both isotopically labelled d4-homocysteine and d3-cysteine as internal standards.
Immunofluorescence
To explore mechanisms of neurodegeneration, levels of apoptosis using active caspase-3 and the cellular response with hypoxia-inducible After which, all animals were placed on a control diet (CD) for 4 weeks and then underwent unilateral photothrombosis (PT) damage to their sensorimotor cortex. All animals received PT and immediately after one group of Mthfr +/+ and Mthfr +/− mice were placed on a supplemented diet (SD) and all remaining animals were maintained on CD. Neurological score and motor function were assessed using the forepaw asymmetry and accelerated rotarod tasks 4 weeks after PT damage. At the completion of experiments animals were euthanized, brain tissue and blood were collected for analysis. Body weight of animals prior to and after PT damage (B), weights were collected on a weekly basis. Fig. 2 . Impact of MTHFR-deficiency and supplemented (SD) or control (CD) diets on neurological score and motor function 4 weeks after photothrombosis (PT) damage to sensorimotor cortex. Mthfr +/+ and Mthfr +/− neurological score, a perfect score is equal to 0 (A). Performance on accelerating rotarod, latency to fall (B) and distance travelled (C). Forepaw asymmetry usage as measured by cylinder task (D). Data represent mean + SEM of 9-10 animals per group. * p < .05, Tukey's pairwise comparison between as defined between indicated groups. factor 1-alpha (HIF-α) were investigated. Primary antibodies included rabbit anti-active caspase-3 (1:100, Cell Signaling Technologies), rabbit anti-HIF-α (1:100, AbCam), and mouse anti-neuronal nuclei (NeuN) (1:200, AbCam) were used and diluted in 0.5% Triton X. Brain tissue was incubated overnight at 4°C. The following day, secondary antibodies (1:200, Cell Signaling Technologies) were incubated at room temperature for 2 h and then stained with 4′, 6-diamidino-2-phenylindole (DAPI) (1:10, 000). In brain tissue within the ischemic core, colocalization of active caspase-3, or HIF-α with NeuN labelled neurons were counted and averaged per animal. Data from five animals per group were analyzed.
Statistical analysis
All data were analyzed by two individuals that were blinded to experimental treatment groups. GraphPad Prism 6.0 was used to analyze all data from the study. Two-way ANOVA analysis was performed when comparing the mean measurement of both genotype and dietary group for behavioral testing, plasma homocysteine measurements, lesion volume, and immunofluorescence staining. Significant main effects of two-way ANOVAs were followed up with Tukey's post-hoc test to adjust for multiple comparisons. All data are presented as mean ± standard error of the mean (SEM). Statistical tests were performed using a significance level of 0.05.
Results
Body weight and mortality after ischemic damage
Two animals (Mthfr +/+ and Mthfr +/− ) were lost after PT damage. To assess health animals were weighed weekly. There was no change in body weight between groups prior to or after damage ( Fig. 1B, F ( 1,33 ) = 45.5, p = .27).
Motor impairments are reduced after ischemic damage in Mthfr +/− mice on supplemented Vitamin-B diet
To assess functional outcome after SD and PT, we measured function of mice 4 weeks after damage. We evaluated function using the Bederson exam and observed a diet effect in the neuroscore ( Fig. 2A, F ( 1,33 ) = 10.15, p < .01). Mthfr +/− mice on the SD had a lower score indicating that they were less impaired when compared to CD mice (p < .05). The accelerating rotarod test revealed that there was a diet effect on the latency to fall (Fig. 2B, F ( 1,33 ) = 5.583, p < .05) and distance travelled (Fig. 2C, F ( 1,33 ) = 7.504, p < .05). Mthfr +/− mice on the SD were able to stay on the accelerating rotarod for longer (p < .05) and travelled further (p < .05) when compared to Mthfr +/+ CD animals. Furthermore, there was a genotype effect observed on the forepaw asymmetry task (Fig. 2D, F ( 1,33 ) = 10.08, p < .01), SD Mthfr +/− mice used their impaired paw more to explore the cylinder. We used the ladder beam task to measure skilled motor function. There was no difference between groups in the movement score of impaired (F ( 1,33 ) = 2.69, p = .12) and non-impaired (F ( 1,33 ) = 1.5, p = .24) limbs. The number of errors made by animals when crossing the ladder beam were not different between groups and impaired (F ( 1,33 ) = 3.9, p = .06) and non-impaired (F ( 1,33 ) = 1.77, p = .20) limbs.
Plasma homocysteine levels and lesion volume decreased in Mthfr +/− supplemented mice
Total plasma homocysteine (tHcy) levels were elevated in Mthfr +/− animals, there was diet and genotype interaction (Fig. 3A, F ( 1,33 ) = 20.25, p < .05). There were no changes in total cysteine (tCys) levels between groups (Fig. 3B, F ( 1,33 ) = 2.4, p = .14).
Four weeks after PT and SD, we quantified lesion volume and representative images are shown in Fig. 3C from all groups. We observed a diet effect (Fig. 3C, F( 1,33 ) = 25.90, p < .01). Both Mthfr +/+ and Mthfr +/− mice on SD had smaller lesion volumes when compared to CD mice (respective to genotype) (p < .05).
Increased apoptosis and HIF1-α levels within ischemic core
In the brain, within the ischemic core, we measured apoptosis using active caspase-3. Representative images from all groups are shown in Fig. 4A to D. The number of active caspase-3 and NeuN co-localized cells were quantified and a main genotype effect was observed (Fig. 4E , F ( 1,16 ) = 6.19, p < .05), there were no pairwise group differences.
Additionally, we measured levels of HIF-α, an important cellular regulator of response after stroke, within the ischemic core. Representative images from all groups are shown in Fig. 5A to D. The number of cells co-localized with HIF-α and NeuN were quantified and there was a diet (Fig. 5E, F ( 1,16 ) = 40.26, p < .01) and genotype (F ( 1,16 ) = 12.32, p < .05) main effects. Mthfr +/− on an SD had more positive cells when compared to all other groups (p < .05).
Discussion
Diet is a modifiable risk factor for onset and progression of stroke (Mozaffarian et al., 2015) . We have previously reported the positive impact of dietary supplementation after stroke . The aim of the present study was to investigate the impact of dietary supplementation with the biologically active form of folic acid, 5-me-thylTHF, combined with choline, and vitamin B12 after ischemic stroke using the photothrombosis model in aged male Mthfr +/+ and Mthfr +/− mice. In the present study we observed fewer motor impairments in Mthfr +/− mice fed the supplemented diet (SD). Furthermore, tHcy levels and lesion volumes were reduced in Mthfr +/+ and Mthfr +/− SD animals. In brain tissue within the damage site, there were reduced levels of apoptotic cell death and increased cellular response in Mthfr +/ − SD mice.
High levels of homocysteine are associated with an increased risk of stroke (Castro et al., 2006; Han et al., 2015; The Homocysteine Studies Collaboration, 2002) and development of atherosclerosis (Wu et al., 2013; Zhao et al., 2017a Zhao et al., , 2017b . In previous trials, lowering levels of tHcy with folic acid supplementation was reported to have no effect on clinical outcomes (Bonaa, 2006; House et al., 2010; Toole et al., 2004) . During these trials, there were several factors that were not considered, such as diseases and, baseline status of participants. For example, administration of folic acid does not reduce levels of homocysteine in chronic renal failure patients, additionally, hyperhomocysteinemia is a risk factor for the development of atherosclerosis in these patients (Bostom and Lathrop, 1997; Buccianti et al., 2002) . Supplementation with 5-methylTHF in chronic renal failure patients has been reported to have positive effects, such as improved vasodilation of brachial artery Fig. 4 . Brain tissue sections co-stained with active caspase-3 (red), neuronal nuclei (NeuN, green), and 4′, 6-diamidino-2-phenylindole DAPI (blue). Active caspase-3 levels within the ischemic core of Mthfr +/+ and Mthfr +/− in supplemented (SD) and control (CD) diet mice, 4 weeks after photothrombosis (PT) damage. Data represent mean ± SEM of 10 animals per group. Genotype main effect, p < .05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) (Buccianti et al., 2002) .
The positive impact of 5-methylTHF supplementation has been reported in other patient groups. A study measuring the impact of 5-methylTHF supplementation on thrombosis reported a reduction in homocysteine levels and oxidative stress in 45 patients with the MTHFR677TT genotype. The supplementation took place for 4 weeks, but the positive impact was reported for 2 months after supplementation has ended (Coppola et al., 2005) . In non-disease populations, supplementation with 5-methylTHF in pregnant women with the MTHFR677TT genotype has resulted in positive effects, such as reducing levels of homocysteine (Fohr et al., 2002; Litynski et al., 2002) . The antioxidant properties of 5-methylTHF may exert the positive effects we observed in the present study, although moderation should be exercised (Baierle et al., 2017) . Furthermore, implementing 5-me-thylTHF supplementation might require further investigation, since there are no established reference values and over supplementation should also be considered (Baierle et al., 2017) .
The MTHFR677C➔T polymorphism has been associated with increased risk for stroke (Abhinand et al., 2017; Song et al., 2016) and is further complicated when folate status is considered (Holmes et al., 2011; Tian et al., 2017) . Increased levels of homocysteine associated with MTHFR polymorphism have been linked to severity of stroke (Matsui et al., 2001) . In hypertensive patients with the MTHFR677TT polymorphism the China Stroke Primary Prevention Trial, reported that enalapril in combination with folic acid reduced levels of homocysteine and the number of ischemic stroke events (Zhao et al., 2017a (Zhao et al., , 2017b , highlighting the importance of tailored interventions. The Mthfr +/− mouse models aspects of the MTHFR polymorphism (Chen et al., 2001) , such as increased levels of homocysteine. In our previous work, we have reported that Mthfr +/− mice have worse outcomes after ischemic damage . We have also shown that mechanisms through which this occurs include reduced neuronal and astrocytic viability . In the present study within the damage area, we observed increased levels of HIF-1α in SD Mthfr +/− mice. HIF-1α is a master regulator of cell response to hypoxia, since it leads to increased expression of several genes involved in the adaptation of oxygen availability and angiogenesis (Cunningham et al., 2012; Jiang et al., 2001) . In the kidney, HIF-1α stabilizes cells after ischemia and interference with HIF-1α promotes tissue damage and dysfunction (Conde et al., 2012) . These results support our previous work, in which we report increased HIF-1α levels in primary astrocyte cultures from Mthfr +/− and Mthfr −/− embryos after a hypoxia treatment . Increased levels of HIF-1α in SD Mthfr +/− mice may be another adaptive response to compensate for damage in the other Fig. 5 . Impact of MTHFR deficiency, supplemented (SD) and control (CD) diet on hypoxia induced factor-alpha (HIF-α, red) levels within the ischemic core 4 weeks after photothrombosis (PT) damage. Brain tissue sections co-stained with neuronal nuclei (NeuN, green), and 4′, 6-diamidino-2-phenylindole DAPI (blue). Data represent mean ± SEM of 9-10 animals per group. * p < .05 and **p < .01, Tukey's pairwise comparison between indicated groups. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) hemisphere.
Precision medicine represents personalized care that is based on advancements in genetics (Henshall, 2018) . In the field of stroke, there is a need to tailor treatment to the molecular basis of the disease and this could be facilitated through precision medicine (Henshall, 2018) , since the current methods of diagnosing stroke do not adequately reflect the heterogeneity of patient populations (Hinman et al., 2017) . The data presented in this study outlines the benefits of supplementing with the active form of folate, 5-methylTHF, in a mouse model with reduced enzymatic activity of MTHFR. Additionally, in recent years, data has suggested that combining therapies may be more effective in treating stroke affected individuals (Amaro et al., 2007; Wang et al., 2015) . The dietary supplementation used in the present study can easily be implemented in combination with other therapies, since it is relatively inexpensive and safe. Using personalized medicine, in patients with the MTHFR polymorphism and/or older adults, supplementation could start prior to a stroke, in an attempt to reduce functional impairments after a stroke.
Conclusion
5-methylTHF versus folic acid supplementation can reduce the negative effects of unmetabolized folic acid in the peripheral circulation, including the brain (Bailey and Ayling, 2018; Scaglione and Panzavolta, 2014; Smith, 2010) . High levels of folates have the potential to mask symptoms of vitamin B12 deficiency (Scaglione and Panzavolta, 2014) , which is common in older patients (Zhang et al., 2016) . In conclusion, the data presented in this study provides evidence that dietary supplementation with 5-methylTHF, vitamin B12, and choline may help alleviate some of the negative symptoms associated with ischemic stroke, especially in older patients and individuals with the MTHFR677C➔T polymorphism. The mechanism through which these functional changes may be occurring could be through an increased cellular response after hypoxia and reduced cell death. 
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